{"id":14049,"date":"2021-06-19T20:46:44","date_gmt":"2021-06-19T19:46:44","guid":{"rendered":"https:\/\/www.fundacionisabelgemio.com\/uncategorized\/consulta-publica-union-europea-sobre-medicamentos-para-ninos-y-para-enfermedades-raras-actualizacion-de-las-normas"},"modified":"2021-06-19T20:49:45","modified_gmt":"2021-06-19T19:49:45","slug":"consulta-publica-union-europea-sobre-medicamentos-para-ninos-y-para-enfermedades-raras-actualizacion-de-las-normas","status":"publish","type":"post","link":"https:\/\/www.fundacionisabelgemio.com\/en\/uncategorized\/consulta-publica-union-europea-sobre-medicamentos-para-ninos-y-para-enfermedades-raras-actualizacion-de-las-normas","title":{"rendered":"Todos los datos para participar en la Consulta P\u00fablica (Uni\u00f3n Europea) sobre Medicamentos para ni\u00f1os y para enfermedades raras: actualizaci\u00f3n de las normas"},"content":{"rendered":"<header class=\"ecl-site-header-standardised\">\n<div class=\"ecl-container ecl-menu__container\">\n<div class=\"ecl-menu__site-name\">Medicamentos para ni\u00f1os y para enfermedades raras: actualizaci\u00f3n de las normas<\/div>\n<div>\n<div id=\"publication-details\" class=\"ecl-u-mb-l ng-star-inserted\">\n<article class=\"ecl-u-d-flex ecl-u-pt-m ecl-u-border-bottom ecl-u-border-color-grey-15 ng-star-inserted\">\n<div class=\"ecl-u-flex-grow-1\">\n<p class=\"ecl-u-type-paragraph ecl-u-type-color-grey-100 ecl-u-mt-xs ng-star-inserted\">La Comisi\u00f3n quiere saber lo que pensamos:<\/p>\n<\/div>\n<\/article>\n<\/div>\n<div id=\"publication-details\" class=\"ecl-u-mb-l ng-star-inserted\">\n<div class=\"ecl-u-mb-m ng-star-inserted\">\n<div class=\"ng-star-inserted\">Gracias a las consultas p\u00fablicas abiertas, se puede opinar sobre diversos aspectos de la legislaci\u00f3n y las pol\u00edticas de la UE antes de que la Comisi\u00f3n finalice sus propuestas.<\/div>\n<\/div>\n<div class=\"ecl-u-mb-m ng-star-inserted\"><button class=\"ecl-button--call ecl-button\" tabindex=\"0\"><span class=\"ecl-button__container\">Ir a la <a href=\"https:\/\/ec.europa.eu\/info\/law\/better-regulation\/have-your-say\/initiatives\/12767-Medicamentos-para-ninos-y-para-enfermedades-raras-actualizacion-de-las-normas\/public-consultation_es\">consulta<\/a><\/span><\/button><\/div>\n<\/div>\n<\/div>\n<div><\/div>\n<div class=\"ecl-menu__site-name\">Consulta p\u00fablica<\/div>\n<\/div>\n<\/header>\n<div class=\"ecl-container\">\n<div class=\"ux-block-content\" data-e2e=\"ux-block-content\">\n<div class=\"ecl-row ng-star-inserted\">\n<div class=\"ecl-col-md-3 section ecl-col-sm-12\">\n<div class=\"sidebar-items sidebar-items--inner-navigation-sidebar\" role=\"menubar\" aria-label=\"sidebar-items\" data-e2e=\"ux-layout-sidebar-items\">\n<nav class=\"timeline-navigation ng-star-inserted\">\n<ul class=\"timeline-navigation__list\">\n<li class=\"timeline-navigation__list__item timeline-navigation__list__item--current timeline-navigation__list__item--multiple ng-star-inserted\">\n<div class=\"ecl-u-mb-xs ng-star-inserted\">\n<div class=\"ecl-u-type-m ecl-u-mb-xs\" translate=\"\">Plazo para enviar comentarios<\/div>\n<div><span class=\"ecl-u-type-capitalize\">07 Mayo 2021 &#8211; 30 Julio 2021<\/span><\/div>\n<\/div>\n<h4 class=\"timeline-navigation__list__item__title ng-star-inserted\">Adopci\u00f3n por la Comisi\u00f3n<\/h4>\n<div class=\"ecl-u-mb-xs ng-star-inserted\">\n<div class=\"ecl-u-type-m ecl-u-mb-xs\" translate=\"\">Prevista para<\/div>\n<div>Primer trimestre 2022<\/div>\n<\/div>\n<\/li>\n<\/ul>\n<\/nav>\n<\/div>\n<\/div>\n<section class=\"ecl-col-sm-12 section ecl-col-md-9\">\n<div id=\"initiative-details\" class=\"ecl-u-mb-l\">\n<h2 id=\"INIT_PLANNED\" class=\"ux-u-text-underline\" translate=\"\">Acerca de esta iniciativa<\/h2>\n<div class=\"ecl-row ecl-u-mb-xs ng-star-inserted\">\n<div class=\"ecl-col-md-2 ecl-col-sm-12 ecl-u-type-bold\" translate=\"\">Resumen<\/div>\n<div class=\"ecl-col-sm-12 ecl-col-md-10 initiative-detail-summary\">\n<p>Las normas de la UE para incentivar el desarrollo de medicamentos para ni\u00f1os y para personas con enfermedades raras llevan casi 20 a\u00f1os en vigor. Esta revisi\u00f3n aborda las deficiencias detectadas en una evaluaci\u00f3n reciente, con el fin de garantizar:<\/p>\n<ul>\n<li>el desarrollo de productos que atiendan a las necesidades espec\u00edficas de los ni\u00f1os y de los pacientes con enfermedades raras<\/li>\n<li>el acceso oportuno de estos grupos a los medicamentos<\/li>\n<li>la existencia de procedimientos eficientes de evaluaci\u00f3n y autorizaci\u00f3n.<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<div class=\"ecl-row ng-star-inserted\">\n<div class=\"ecl-col-md-2 ecl-col-sm-12 ecl-u-type-bold\" translate=\"\">Tema<\/div>\n<div class=\"ecl-col-sm-12 ecl-col-md-10 ecl-u-mb-m\">Salud p\u00fablica<\/div>\n<\/div>\n<div class=\"ecl-row ng-star-inserted\">\n<div class=\"ecl-col-md-2 ecl-col-sm-12 ecl-u-type-bold\" translate=\"\">Tipo de texto legislativo<\/div>\n<div class=\"ecl-col-sm-12 ecl-col-md-10 ecl-u-mb-m\" translate=\"\">Propuesta de reglamento<\/div>\n<\/div>\n<div class=\"ecl-row ecl-u-mb-xs ng-star-inserted\">\n<div class=\"ecl-col-sm-12 ecl-col-md-10 ecl-u-mb-m\"><\/div>\n<\/div>\n<\/div>\n<div id=\"publication-details\" class=\"ecl-u-mb-l ng-star-inserted\">\n<h2 id=\"PLANNING_WORKFLOW\" class=\"ux-u-text-underline ng-star-inserted\">Hojas de ruta<\/h2>\n<div class=\"ecl-u-mb-l ng-star-inserted\">\n<div><\/div>\n<\/div>\n<div class=\"ecl-u-mb-m ng-star-inserted\"><a class=\"ecl-link\" href=\"https:\/\/ec.europa.eu\/info\/law\/better-regulation\/have-your-say\/initiatives\/12767-Medicamentos-para-ninos-y-para-enfermedades-raras-actualizacion-de-las-normas\/feedback_es?p_id=16162779\"><span translate=\"\">Ver hojas de ruta recibidas &gt;<\/span>\u00a0&gt;<\/a><\/div>\n<div id=\"initiative-attachments\">\n<div class=\"ecl-file ecl-u-mt-l\">\n<div class=\"ecl-file__container\">\n<div class=\"ecl-file__info\">\n<div class=\"ecl-file__title\">Evaluaci\u00f3n inicial de impacto &#8211; Ares(2020)7081640<\/div>\n<div class=\"ecl-file__language\">ingl\u00e9s<\/div>\n<div class=\"ecl-file__meta\">(281.7 KB &#8211; PDF &#8211; 8 p\u00e1ginas)<\/div>\n<\/div>\n<p><a class=\"ecl-file__download ecl-link ecl-link--standalone ecl-link--icon ecl-link--icon-after\" href=\"https:\/\/ec.europa.eu\/info\/law\/better-regulation\/\" download=\"\"><span class=\"ecl-link__label\">Descargar<\/span>\u00a0\u00a0<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"ecl-u-d-flex ecl-u-flex-row ecl-u-justify-content-between ecl-u-border-bottom ecl-u-mt-l ng-star-inserted\"><\/div>\n<article class=\"ecl-u-d-flex ecl-u-pt-m ecl-u-border-bottom ecl-u-border-color-grey-15 ng-star-inserted\">\n<div class=\"ecl-u-flex-grow-1\"><\/div>\n<\/article>\n<\/div>\n<div id=\"publication-details\" class=\"ecl-u-mb-l ng-star-inserted\">\n<div class=\"ecl-u-mb-m ng-star-inserted\"><\/div>\n<div id=\"initiative-attachments\">FUENTE: COMISION EUROPEA<\/div>\n<\/div>\n<div id=\"publication-details\" class=\"ecl-u-mb-l ng-star-inserted\">\n<div class=\"ecl-u-mb-l ng-star-inserted\">\n<div><\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Medicamentos para ni\u00f1os y para enfermedades raras: actualizaci\u00f3n de las normas La Comisi\u00f3n quiere saber lo que pensamos: Gracias a [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":20059,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[715,713],"tags":[],"class_list":["post-14049","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cientificas-en","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/www.fundacionisabelgemio.com\/en\/wp-json\/wp\/v2\/posts\/14049","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fundacionisabelgemio.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fundacionisabelgemio.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fundacionisabelgemio.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fundacionisabelgemio.com\/en\/wp-json\/wp\/v2\/comments?post=14049"}],"version-history":[{"count":1,"href":"https:\/\/www.fundacionisabelgemio.com\/en\/wp-json\/wp\/v2\/posts\/14049\/revisions"}],"predecessor-version":[{"id":14052,"href":"https:\/\/www.fundacionisabelgemio.com\/en\/wp-json\/wp\/v2\/posts\/14049\/revisions\/14052"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fundacionisabelgemio.com\/en\/wp-json\/wp\/v2\/media\/20059"}],"wp:attachment":[{"href":"https:\/\/www.fundacionisabelgemio.com\/en\/wp-json\/wp\/v2\/media?parent=14049"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fundacionisabelgemio.com\/en\/wp-json\/wp\/v2\/categories?post=14049"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fundacionisabelgemio.com\/en\/wp-json\/wp\/v2\/tags?post=14049"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}